Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Medical genetics · GLS gain-of-function and MSMO1 deficiency

Building Your Child's Medical Care Team

At a Glance

Care for children with GLS or MSMO1 disorders is best coordinated by a metabolic geneticist, with pediatric neurology, ophthalmology, and dermatology involved as needed. Bring complete genetic and laboratory reports, imaging files, a dated health history, and a treatment log to specialist visits.

Managing a child with an ultra-rare symptom cluster requires more than just a pediatrician. You are building a “medical home” composed of specialists who must talk to one another in a coordinated team model to understand the full picture of your child’s health. Because your child’s condition involves the eyes, brain, skin, and internal chemistry, your care team will likely be larger and more specialized than those of other children [1][2]. Local pediatricians still have important roles in daily health and acute illness.

The Core Team

Your core team is the group of doctors who will manage the most critical aspects of your child’s condition.

The Metabolic Geneticist (The Lead)

This specialist—often called a biochemical geneticist—is the coordinator of the team. They specialize in inborn errors of metabolism, conditions where the body cannot properly process certain chemicals [1].

  • Their Role: They interpret complex metabolic labs, such as glutamate levels and sterol profiles, and manage treatments alongside dietitians and specialty pharmacies [3][4].
  • Vetting Question: “How do you coordinate with the other specialists on this team to ensure our child’s metabolic treatments aren’t interfering with their neurological or skin care?” [1]

The Pediatric Neurologist or Neurogeneticist

This specialist focuses on the brain and nervous system. For children with GLS or MSMO1, they manage the neurological manifestations like developmental delay and epilepsy [2][5].

  • Their Role: They order and interpret brain scans (MRI and MRS) and EEGs, and they manage anti-seizure medications [2].
  • Vetting Question: “What is your experience in managing ‘excitotoxicity’ or brain-chemistry imbalances that don’t respond to standard epilepsy drugs?” [5]

The Pediatric Ophthalmologist

Because infantile cataracts are often the first sign of these disorders, this doctor is essential for preserving your child’s vision.

  • Their Role: They perform cataract surgery and provide long-term monitoring for complications like glaucoma [6].

The Pediatric Dermatologist

If your child has MSMO1 deficiency, a dermatologist is needed to manage the red, scaly skin patches (psoriasiform dermatitis) [7][8].

  • Their Role: They can prescribe specialized, compounded topical treatments that are not available at standard pharmacies [8].

Supporting Specialists

Depending on your child’s specific needs, you may also add:

  • Metabolic Dietitian: To manage nutrition and any specialized formulas [9][10].
  • Genetic Counselor: To help you understand genetic reports and the risks for future pregnancies [11][12].
  • Metabolic Social Worker: To help with school accommodations, insurance hurdles, and the emotional weight of a rare diagnosis [13].

The First 30 Days and the Medical Binder

When navigating a new diagnosis, set up an after-hours written plan for who to call regarding seizures, acute illness, new eye symptoms, or medication side effects.

When visiting a specialized metabolic center, the doctors need the “raw data,” not just a summary. Prepare a physical or digital binder containing:

  1. Genetic Reports: Bring the full, multi-page report from the lab (e.g., Invitae, GeneDx), including the specific “variant” codes and whether it was de novo or inherited [14][15].
  2. Original Lab Results: Bring reports that show the units and reference ranges for amino acid panels and sterol profiles. Simply knowing a level was “high” is often not enough for a specialist [3][4].
  3. Imaging Files: Bring a disc or digital access to actual MRI/MRS images, not just the radiologist’s written report [4][16].
  4. Chronological History: A simple timeline of when cataracts were found, when skin issues started, and the exact dates of any surgeries or seizures [17][18].
  5. Treatment Log: A list of all medications, supplements, and formulas, including the dose and how your child reacted to each one [19][20].

Common questions in this guide

Which specialists should care for a child with a GLS or MSMO1 disorder?
A metabolic geneticist, also called a biochemical geneticist, can lead and coordinate the team. A pediatric neurologist or neurogeneticist may address development, seizures, and brain testing, while a pediatric ophthalmologist and dermatologist manage cataracts, glaucoma monitoring, and skin disease. A metabolic dietitian, genetic counselor, and social worker can add nutrition, family-planning, school, and practical support.
What does a metabolic geneticist do for my child?
This specialist interprets complex metabolic and genetic results, including glutamate and sterol testing, and coordinates treatment with other specialists, dietitians, and specialty pharmacies. They can also help coordinate specialized testing and explain what the results may mean for your child's care.
What should I bring to a rare-disease or metabolic clinic visit?
Bring the complete genetic report, including the exact variant and whether it was inherited or new; original lab reports with units and normal ranges; and the actual brain imaging files, not only the written report. Also bring a dated history of cataracts, skin changes, seizures, and surgeries, plus a list of every medicine, supplement, and formula with doses and reactions.
Why does my child need a pediatric ophthalmologist for infantile cataracts?
Infantile cataracts can threaten vision and may be an early sign of an underlying metabolic or genetic disorder. A pediatric ophthalmologist can perform or coordinate cataract surgery and monitor for later problems such as glaucoma.
How are neurological and skin problems managed in these disorders?
A pediatric neurologist or neurogeneticist may evaluate development and seizures with brain imaging and electrical brain-wave testing, then manage anti-seizure medicines when needed. For MSMO1 deficiency, a pediatric dermatologist can treat red, scaly skin patches, sometimes using specially prepared topical medicines. The specialists should share information so one treatment plan supports the whole child.
What should be in my child's after-hours medical plan?
The plan should name who to call first for a seizure, sudden illness, new eye symptoms, or a medication side effect, including an after-hours contact. Keep an updated medication and treatment list with the plan and share it with caregivers and the medical team.

Get notified when new evidence is published on infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    Common metabolic disorder (inborn errors of metabolism) concerns in primary care practice.

    Agana M, Frueh J, Kamboj M, et al.

    Annals of translational medicine 2018; (6(24)):469 doi:10.21037/atm.2018.12.34.

    PMID: 30740400
  2. 2

    Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism.

    Ebrahimi-Fakhari D, Saffari A, Wahlster L, et al.

    Brain : a journal of neurology 2016; (139(Pt 2)):317-37 doi:10.1093/brain/awv371.

    PMID: 26715604
  3. 3

    Molecular genetics of phenylketonuria and tetrahydrobiopterin deficiency in Jordan.

    Carducci C, Amayreh W, Ababneh H, et al.

    JIMD reports 2020; (55(1)):59-67 doi:10.1002/jmd2.12130.

    PMID: 32905092
  4. 4

    Delayed Biotin Therapy in a Child with Atypical Profound Biotinidase Deficiency: Late Arrival of the Truth and a Lesson Worth Thinking.

    Liu S, Zhang Y, Deng Z, et al.

    International journal of molecular sciences 2023; (24(12)) doi:10.3390/ijms241210239.

    PMID: 37373384
  5. 5

    Clinical and biochemical footprints of inherited disorders of autophagy.

    Jungbluth H, Dafsari HS, Ferreira CR, Blau N

    Molecular genetics and metabolism 2026; (149(1-2)):110248 doi:10.1016/j.ymgme.2026.110248.

    PMID: 42691780
  6. 6

    Incidence and Risk Factors of Early-onset Glaucoma following Pediatric Cataract Surgery in Egyptian Children: One-year Study.

    I Gawdat G, M Youssef M, M Bahgat N, et al.

    Journal of current glaucoma practice 2017; (11(3)):80-85 doi:10.5005/jp-journals-10028-1229.

    PMID: 29151681
  7. 7

    New Homozygous Missense MSMO1 Mutation in Two Siblings with SC4MOL Deficiency Presenting with Psoriasiform Dermatitis.

    Kalay Yildizhan I, Gökpınar İli E, Onoufriadis A, et al.

    Cytogenetic and genome research 2020; (160(9)):523-530 doi:10.1159/000511126.

    PMID: 33161406
  8. 8

    MSMO1 deficiency: a potentially partially treatable, ultrarare neurodevelopmental disorder with psoriasiform dermatitis, alopecia and polydactyly.

    Tkemaladze T, Bratland E, Bregvadze K, et al.

    Clinical dysmorphology 2023; (32(3)):97-105 doi:10.1097/MCD.0000000000000461.

    PMID: 37195326
  9. 9

    Long-Term Management of Patients with Mild Urea Cycle Disorders Identified through the Newborn Screening: An Expert Opinion for Clinical Practice.

    Burlina A, Gasperini S, la Marca G, et al.

    Nutrients 2023; (16(1)) doi:10.3390/nu16010013.

    PMID: 38201843
  10. 10

    Hormonal Crossroads in Inborn Errors of the Metabolism Impact of Puberty and Dietary Interventions on Metabolic Health.

    Lundqvist T, Stenlid R, Halldin M

    Metabolites 2025; (15(4)) doi:10.3390/metabo15040235.

    PMID: 40278364
  11. 11

    Case Report: Prenatal neurological injury in a neonate with pyruvate carboxylase deficiency type B.

    Xue M

    Frontiers in endocrinology 2023; (14()):1199590 doi:10.3389/fendo.2023.1199590.

    PMID: 37484962
  12. 12

    Primary systemic carnitine deficiency: Phenotypic variability, diagnostic challenges, and long-term outcomes.

    Pınar E, Zubarioglu T, Babazade H, et al.

    Pediatrics international : official journal of the Japan Pediatric Society 2025; (67(1)):e70211 doi:10.1111/ped.70211.

    PMID: 41048097
  13. 13

    Examining the role of social workers within clinical metabolic genetics care.

    Shim S, Cory D, Wixson G, et al.

    Molecular genetics and metabolism reports 2026; (48()):101326 doi:10.1016/j.ymgmr.2026.101326.

    PMID: 42294407
  14. 14

    Next generation deep sequencing corrects diagnostic pitfalls of traditional molecular approach in a patient with prenatal onset of Pompe disease.

    Tsai AC, Hung YW, Harding C, et al.

    American journal of medical genetics. Part A 2017; (173(9)):2500-2504 doi:10.1002/ajmg.a.38333.

    PMID: 28657663
  15. 15

    Juvenile Paget disease with unique compound heterozygous sequence variants in the TNFRSF11B gene.

    Horackova J, Taslerova R, Bayer M, et al.

    Orphanet journal of rare diseases 2025; (20(1)):409 doi:10.1186/s13023-025-03804-2.

    PMID: 40775369
  16. 16

    Early-onset juvenile Paget disease associated with a homozygous intronic TNFRSF11B variant: a 2-year follow-up.

    Meral R, Gökoğlu M

    Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(11)):1200-1204 doi:10.1515/jpem-2026-0332.

    PMID: 42528457
  17. 17

    Clinical Characteristics of Arginase 1 Deficiency: Natural History Insights From International Clinical Trials.

    Rudebeck M, Braverman N, Chang R, et al.

    Journal of inherited metabolic disease 2026; (49(2)):e70156 doi:10.1002/jimd.70156.

    PMID: 41651652
  18. 18

    Clouds over IMD? Perspectives for inherited metabolic diseases in adults from a retrospective cohort study in two Swiss adult metabolic clinics.

    Gariani K, Nascimento M, Superti-Furga A, Tran C

    Orphanet journal of rare diseases 2020; (15(1)):210 doi:10.1186/s13023-020-01471-z.

    PMID: 32811506
  19. 19

    Characterization of Treatment Utilization in a Metabolic Genetics Clinic.

    Riedy M, Briggs J, Huang T

    The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 2025; (30(6)):773-778 doi:10.5863/JPPT-24-00113.

    PMID: 41415932
  20. 20

    Examining Roles, Challenges, and Opportunities Within the Metabolic Genetics Workforce.

    Simpson K, Offord S, Suares C, Vockley J

    American journal of medical genetics. Part A 2025; (197(2)):e63889 doi:10.1002/ajmg.a.63889.

    PMID: 39350662

This page is for caregivers of children with rare metabolic disorders and is for informational purposes only; it does not replace medical advice. Your child's care team should interpret test results and plan treatment.